South Rampart Pharma receives $1.9M NIH STTR Fast-Track Grant
PAIN RELIEF INNOVATION
South Rampart Pharma is committed to improving the lives of people suffering from acute, chronic and neuropathic pain by developing a new class of non-opioid pain medicines that do not have the toxicities found in current over the counter and prescription medicines.